EZH2-inhibitor DZNep enhances apoptosis of renal tubular epithelial cells in presence and absence of cisplatin
Abstract Background The enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase and induces the trimethylation of histone H3 lysine 27 (H3K27me3) in the promoter of many key genes; EZH2 acts as a transcriptional repressor and is an epigenetic regulator for several cancers. However, the rol...
Main Authors: | Si-qi Chen, Jia-qi Li, Xiao-qiao Wang, Wen-jing Lei, Hao Li, Jiao Wan, Zheng Hu, Yao-wei Zou, Xiao-yu Wu, Hong-xin Niu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-05-01
|
Series: | Cell Division |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13008-020-00064-3 |
Similar Items
-
DZNep inhibits the proliferation of colon cancer HCT116 cells by inducing senescence and apoptosis
by: Mingquan Sha, et al.
Published: (2015-05-01) -
EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies
by: Ivana Samaržija, et al.
Published: (2022-09-01) -
DZNep, an inhibitor of the histone methyltransferase EZH2, suppresses hepatic fibrosis through regulating miR-199a-5p/SOCS7 pathway
by: Rongrong Ding, et al.
Published: (2021-05-01) -
EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
by: Bohan Wang, et al.
Published: (2023-06-01) -
Role of EZH2 in Uterine Gland Development
by: Nan Ni, et al.
Published: (2022-12-01)